Literature DB >> 2846767

Human papillomavirus type 52: a new virus associated with cervical neoplasia.

K Shimoda1, A T Lorincz, G F Temple, W D Lancaster.   

Abstract

Analysis of biopsies of cervical intraepithelial neoplasia (CIN) revealed a high percentage of human papillomavirus (HPV) sequences that would hybridize to a mixture of HPV probes only under conditions of relaxed stringency. The DNA sequences of one of these viruses was molecularly cloned and shown to be a new HPV, type 52 (HPV-52). This virus is most closely related to HPV-33. Hybridization analysis with restriction fragments of HPV-52 showed collinearity with the HPV-33 genome. DNA sequencing revealed a high level of conservation between the two viruses within the L1 open reading frame but significant divergence in the non-coding region of the viral genomes. Prevalence studies indicated that HPV-52 sequences were present in three of 137 (2%) CIN and in one of 48 (2%) cervical squamous cell cancers studied in the U.S.A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846767     DOI: 10.1099/0022-1317-69-11-2925

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Amplification of human papillomavirus DNA sequences by using conserved primers.

Authors:  L Gregoire; M Arella; J Campione-Piccardo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions.

Authors:  A J van den Brule; P J Snijders; P M Raaphorst; H F Schrijnemakers; H Delius; L Gissmann; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

Review 3.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16.

Authors:  Itzel E Calleja-Macias; Luisa L Villa; Jose C Prado; Mina Kalantari; Bruce Allan; Anna-Lise Williamson; Lap-Ping Chung; Robert J Collins; Rosemary E Zuna; S Terence Dunn; Tang-Yuan Chu; Heather A Cubie; Kate Cuschieri; Magnus von Knebel-Doeberitz; Claudia R Martins; Gloria I Sanchez; F Xavier Bosch; Nubia Munoz; Hans-Ulrich Bernard
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico.

Authors:  T M Becker; C M Wheeler; N S McGough; S W Jordan; M Dorin; J Miller
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

6.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.

Authors:  A P Cullen; R Reid; M Campion; A T Lörincz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 7.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

8.  Detection of human papillomavirus (HPV) type 16 and 52b in cervical cancer tissues by Southern blot hybridization and polymerase chain reaction (PCR).

Authors:  N Yaegashi; H Yajima; K Shikano; R Konno; S Sato; K Noda; A Yajima
Journal:  Virus Genes       Date:  1990-12       Impact factor: 2.332

9.  Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy.

Authors:  Maria Lina Tornesello; Maria Luisa Duraturo; Luigi Buonaguro; Gabriele Vallefuoco; Roberto Piccoli; Stefano Palmieri; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2007-01-03       Impact factor: 2.965

10.  Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers.

Authors:  H Yoshikawa; T Kawana; K Kitagawa; M Mizuno; H Yoshikura; A Iwamoto
Journal:  Jpn J Cancer Res       Date:  1991-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.